Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Clinical trial NCT01736592 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT01736592
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stargardt's Disease

Start date: 2012-12-14
Primary completion: 2033-08-29
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.